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discriminative power. The results showed that MRI volumes 
measured before and during RCH have a great potential to 
better individualize adaptive RCH. 
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Purpose or Objective: Dynamic contrast enhanced (DCE) MRI 
is becoming an increasingly important tool for assessing 
tumour response in Radiotherapy (RT). Important 
characteristics are spatial and temporal resolution and in 
lung this is further complicated by the effects of respiratory 
motion. A common approach is to acquire fast gradient-echo 
imaging utilising k-space sharing to provide optimum 
temporal resolution and to collect data during short 
‘windows’ of breath-holds over the time course. However 
patient compliance during breath hold manoeuvres can lead 
to tumour displacement and introduce error in analysis. 
Radial acquisitions can alleviate motion by oversampling the 
centre of k-space albeit with reduced temporal resolution. 
The purpose of this study was to evaluate whether such a 
‘stack-of-stars’ acquisition can be used with high enough 
resolution for the DCE sequence to provide a complete free 
breathing RT planning protocol in lung patients. 
 
Material and Methods: Institutional review board approval 
was obtained. Two patients receiving lung radiotherapy 
underwent DCE-MRI on our dedicated wide bore 3 Tesla 
system (Skyra, Siemens) using an 18 channel flexible coil and 
32 channel table coil. Patients were positioned as per 
treatment setup with their hands above their head. Two DCE 
protocols were examined; a fast gradient-echo sequence 
employing k-space sharing (TWIST) acquired as 5 breath-hold 
periods of 20s each with a spatial and temporal resolution of 
1.5 mm/3 s; and a completely free breathing scan performed 
using a radial acquisition (StarVIBE) with a resolution of 1.8 
mm and 14 s. The acquisition time was approximately 6 
minutes for both sequences. In both cases a rapid pre-
contrast measurement of T1 was acquired using the same 
sequence and two flip angles. Analysis included calculation of 
T1 map and a two-compartment model fit to the data 
(Tissue4D, Siemens) to provide pixel-by-pixel maps of the 
perfusion rate constant. 
 
Results: Figure 1 shows images and analysis taken from both 
sequences. Viewing DCE data in a cine loop revealed large 
movement between frames for TWIST compared to StarVIBE. 
A comparison of signal-time plots shows a typical result 
where failure to maintain and reproduce breath hold has 
produce large variation and discontinuities in the dataset. As 
a result the goodness-of-fit (chi2) was better for StarVIBE 
(0.05) than the corresponding value using TWIST (0.16). 
Although temporal resolution is much poorer with the 
StarVIBE sequence, it was sufficient to sample the early 
upslope phase of the contrast agent. General image quality 
was assessed with radial and motion artefacts scored as being 
negligible. 
 
Conclusion: These initial results show that use of a radial k-
space trajectory as a method of motion compensation 
provides a DCE scan of sufficient image quality and temporal 
resolution which can be used as part of a complete free 
breathing lung protocol. 
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Purpose or Objective: Radiomic image features derived from 
conventional treatment planning CT images have already 
been shown to have prognostic information. For cone-beam 
CT (CBCT) imaging during radiotherapy this has not yet been 
described. Due to the fact that a CBCT image is acquired 
prior to each fraction it has the potential to monitor response 
to treatment. The goal of this study was to investigate the 
stability and the correlation between radiomic features 
derived from planning CT vs. CBCT and between CBCTs of 
different fractions.  
 
Material and Methods: A total of 27 stage II-III NSCLC 
patients who received radiation therapy were included in this 
study. For each patient a treatment planning CT scan was 
acquired and CBCT scans were obtained prior to each 
fraction. The planning CT (CT1), the CBCT of the first (CBCT-
FX1) and second fraction (CBCT-FX2) were used in this study. 
CBCT images were registered to CT1 using automatic rigid 
registration prior to feature extraction. In total, 149 radiomic 
image features were extracted of different feature groups: I) 
tumor intensity, II) texture, III) Laplacian of Gaussian. The 
third group consists of filtered first order features and the 
group was subdivided into 10 groups, according to different 
LoG filter standard deviations ranging from 0.5 mm to 5 mm 
with a 0.5 mm interval. Since a rigid registration was used, 
features related to shape and volume were not analyzed. The 
correlation between features derived from (1) CT1 and CBCT-
FX1 and (2) CBCT-FX1 and CBCT-FX2 were analyzed. 
Correlations were calculated using an intraclass correlation 
coefficient ICC(2,1). An ICC-value above 0.9 was considered a 
good agreement. 
 
Results: For 26% of the 149 analyzed radiomics features, the 
ICC-value was higher than 0.9 for CT1 compared to CBCT-FX1 
(Figure). The ICC-value was above 0.9 for 81% of the features 
when comparing CBCT-FX1 to CBCT-FX2. Specifically for the 
feature group ‘texture’, one of the 44 features had an 
agreement between CT1 and CBCT-FX1 that was higher than 
0.9, but 35 out of 44 did show agreement for CBCT-FX1 vs. 
CBCT-FX2. For ‘tumor intensity’, 2 out of 15 features showed 
a large correlation between CT1 and CBCT-FX1 higher than 
0.9, whereas 10 out of 15 features showed agreement higher 
than 0.9 between CBCT-FX1 and CBCT-FX2 (ICC>0.8 for all). 
All features with ICC above 0.9 for CT1 vs. CBCT-FX1 also 
showed high correlation between CBCT-FX1 and CBCT-FX2. 
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Figure: Percentage of features with ICC>0.9 for CT1 vs. CBCT-
1 and CBCT-1 vs. CBCT-2, displayed for each feature group.  
 
Conclusion: For 26% of the radiomics features there is good 
agreement between CT1 and CBCT. 81% of the image 
features show high correlation between CBCT-FX1 and CBCT-
FX2 where no large differences are expected. In the future, 
radiomic features derived from CBCT images will be 
investigated to monitor changes of CBCT features over the 
course of treatment. One has to be careful with mixing 
radiomic features derived on planning CT and CBCT scans. 
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Purpose or Objective: Tumour sub-volumes for dose 
escalation can be defined using different PET tracers. This 
study compares hypoxic volumes defined by FMISO PET and 
metabolically active volumes defined by FDG PET for patients 
with advanced squamous cell carcinomas of the head and 
neck (SCCHN). 
 
Material and Methods: Imaging data of 14 patients was used, 
which were included in a phase II FMISO dose escalation 
study. Pre-therapy FMISO PET/CT images were acquired four 
hours post tracer injection. FDG PET/CT imaging was 
performed according to the institutional diagnostic protocol. 
The planning CT and the GTV of the primary tumour were 
available. Datasets were deformably co-registered using the 
CT images. Metabolically active sub-volumes were segmented 
in FDG PET images based on a source-to-background method 
with an adaptive threshold. Hypoxic sub-volumes were 
defined using a tumour-to-muscle threshold of 1.4. Expanding 
the volumes by an isotropic margin of five millimeters 
resulted in PTV-prim and potential dose escalation volumes 
PTV-FMISO and PTV-FDG. We analyzed the overlap between 
PTV-FMISO and PTV-FDG. 
 
Results: Mean dose escalation volumes were 19.7 cm³ (0.0-
57.3 cm³) for PTV-FMISO and 39.3 cm³ (17.5-91.9 cm³) for 
PTV-FDG. On average PTV-FDG covered 73.5% of PTV-FMISO 
(4.9-100.0%). Only for two out of fourteen patients (14%) 
PTV-FMISO was completely covered by PTV-FDG. Vice versa 
36.3% of PTV-FDG overlapped with PTV-FMISO (0.0-97.4%). 
PTV-prim from treatment planning was 111.1 cm³ (57.1-201.2 
cm³). Detailed results of the overlap analysis for all patients 
are given in Table 1. 
 
 
Conclusion: PTV-FDG typically covers PTV-FMISO only 
partially and is on average two times larger. Therefore, a 
dose escalation in the metabolically active sub-volume 
partially misses the hypoxic sub-volume. The large volume 
difference suggests that a substantially higher dose 
escalation is feasible in PTV-FMISO than in PTV-FDG. Clinical 
trials are required to compare the efficacy of both methods. 
 
PO-0924  
Histogram analysis of ADCs from DWMRI predicts tumour 
response and survival for rectal cancer 
K. Bakke
1Akershus University Hospital, Department of Oncology, 
Lørenskog, Norway 
1, T. Seierstad2, K.H. Hole2, S. Dueland3, K. 
Flatmark4, A. Hansen Ree1, K. Røe Redalen1 
2Oslo University Hospital, Department of Radiology and 
Nuclear Medicine, Oslo, Norway 
3Oslo University Hospital, Department of Oncology, Oslo, 
Norway 
4Oslo University Hospital, Department of Gastroenterological 
Surgery, Oslo, Norway 
 
Purpose or Objective: Patients with locally advanced rectal 
cancer (LARC) are commonly treated with neoadjuvant 
chemoradiotherapy (CRT) followed by radical surgery. 
However, tumor responses vary considerably and about one 
third of the patients experience poor disease outcome due to 
metastatic progression. We aimed to investigate if apparent 
diffusion coefficients (ADCs) quantified from diffusion-
weighted MRI (DWMRI) predicted histologic tumor response to 
the neoadjuvant treatment and long-term survival. 
Recognizing the tumor heterogeneity we specifically aimed to 
explore if histogram analysis of tumor ADC may reveal more 
useful information than the commonly used mean ADC 
measure. 
 
Material and Methods: Data from 23 prospectively enrolled 
patients receiving induction neoadjuvant chemotherapy 
(NACT) followed by CRT and radical surgery was analyzed. 
DWMRI was acquired at baseline and after NACT. Tumor 
volumes contoured in T2-weighted MR images were 
transferred to tumor ADC maps calculated with b-values 300 
and 900 s/mm2, before ADCs were extracted from all tumor 
voxels and presented as histograms. The predictive 
information contained in the histograms was evaluated using 
receiver operating characteristic (ROC) curve analysis of each 
percentile from 1-100. Study endpoints were histologic tumor 
regression grade (TRG) and 5-year progression-free survival 
(PFS). 
 
Results: Using the change in tumor ADC from baseline to 
NACT completion, we identified a histogram area below 
median (20th–40th percentiles) to be associated with both 
TRG and PFS. By using the 20th percentile, an increase in 
